Skip to content
Webe Honey – Lifestyle
Author:
Deerfield Group
Built for This: Deerfield Group Expands Leadership to Advance Next Phase of Growth, Harnessing Innovation, Technology Anchored in Human Expertise
September 15, 2026
DEERFIELD GROUP ANNOUNCES STRATEGIC INVESTMENT FROM MARTIS CAPITAL TO FUEL NEXT PHASE OF GROWTH
June 30, 2026
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026
Petrichor Names Diagnostics Industry Leader Don Hardison as Operating Partner
May 20, 2026
/C O R R E C T I O N — InMed Pharmaceuticals/
May 19, 2026
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies
May 19, 2026
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 18, 2026
HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
April 28, 2026
Deerfield Group Launches Prismatiq™, an Intuitive Field Enablement Platform Purpose-Built for Life Sciences
April 22, 2026
Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting
April 17, 2026
1
2
Next Page
→